Swanson C et al. |
FK 506-based immunosuppression in clinical pancreas transplantation. |
1995 |
Transplant. Proc. |
pmid:8539827
|
Tesi RJ et al. |
Conversion of pancreas transplants to FK 506 from CsA. |
1995 |
Transplant. Proc. |
pmid:8539828
|
Burke GW et al. |
Use of FK 506 in simultaneous pancreas/kidney transplantation: lack of impairment of glycemic or lipid metabolism. |
1995 |
Transplant. Proc. |
pmid:8539872
|
Burke GW et al. |
The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression. |
1995 |
Transplant. Proc. |
pmid:8539874
|
Wennberg L et al. |
Immunosuppression with leflunomide and cyclosporine prevents pig-to-rat islet xenograft rejection. |
1995 |
Transplant. Proc. |
pmid:8539967
|
Tai J et al. |
In vivo function of pig islet xenografts in immunosuppressed diabetic mice. |
1995 |
Transplant. Proc. |
pmid:8539968
|
Klintmalm GB and Gonwa TA |
Nephrotoxicity associated with cyclosporine and FK506. |
1995 |
Liver Transpl Surg |
pmid:9346596
|
Wong PY et al. |
FK506 in liver transplantation for chronic hepatitis B: in vitro studies on lymphocyte activation and virus replication. |
1995 |
Liver Transpl Surg |
pmid:9346613
|
Monfar M et al. |
Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. |
1995 |
Mol. Cell. Biol. |
pmid:7528328
|
Echigo Y et al. |
Effects of cyclosporine and tacrolimus (FK 506) on acute pancreatitis in mice. |
1995 |
Arch Surg |
pmid:7528496
|
Fukuzaki T et al. |
A protocol with FK 506 for inducing unresponsiveness to murine islet allografts. |
1995 |
Surgery |
pmid:7531371
|
Lemster BH et al. |
IL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy. |
1995 |
Clin. Exp. Immunol. |
pmid:7531627
|
Timerman AP et al. |
Characterization of an exchange reaction between soluble FKBP-12 and the FKBP.ryanodine receptor complex. Modulation by FKBP mutants deficient in peptidyl-prolyl isomerase activity. |
1995 |
J. Biol. Chem. |
pmid:7531689
|
Richter A et al. |
Growth inhibitory effects of FK506 and cyclosporin A independent of inhibition of calcineurin. |
1995 |
Biochem. Pharmacol. |
pmid:7531976
|
Hamasaki Y et al. |
Inhibition of leukotriene production by FK506 in rat basophilic leukemia-1 cells. |
1995 |
Pharmacology |
pmid:7538218
|
Rucay P et al. |
FK 506 as treatment of late acute rejection in liver transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533354
|
Schwartz M et al. |
FK 506 in liver transplantation: correlation of whole blood levels with efficacy and toxicity. The US Multicenter FK 506 Dose Optimization. |
1995 |
Transplant. Proc. |
pmid:7533355
|
Yasuhara M et al. |
Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations. |
1995 |
Transplant. Proc. |
pmid:7533356
|
Platz KP et al. |
OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection. |
1995 |
Transplant. Proc. |
pmid:7533357
|
Bierer BE |
Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin. |
1995 |
Proc. Assoc. Am. Physicians |
pmid:8630742
|
Porayko MK et al. |
Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group. |
1995 |
Transplant. Proc. |
pmid:7533358
|
Mueller AR et al. |
The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A. |
1995 |
Transplant. Proc. |
pmid:7533359
|
Abouljoud MS et al. |
Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group. |
1995 |
Transplant. Proc. |
pmid:7533360
|
Bäckman L et al. |
Whole-blood and plasma levels of FK 506 after liver transplantation: results from the US Multicenter Trial. FK506 Multicenter Study Group. |
1995 |
Transplant. Proc. |
pmid:7533361
|
Fukuzaki T et al. |
Induction of unresponsiveness to islet allografts with donor spleen cell inoculation followed by a single injection of FK 506. |
1995 |
Transplant. Proc. |
pmid:7533407
|
Grochowicz PM et al. |
Synergism of castanospermine and FK 506. |
1995 |
Transplant. Proc. |
pmid:7533408
|
Itoh S and Navia MA |
Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus). |
1995 |
Protein Sci. |
pmid:8563622
|
Tamura K et al. |
Inhibition of insulin production by FK 506 is caused at the transcriptional level in pancreatic beta cell when FK BP-12 content is relatively high. |
1995 |
Transplant. Proc. |
pmid:7533409
|
Kawano K et al. |
Protective effect of FK 506 on hepatic injury following cold ischemic preservation and transplantation: influence on hepatic microcirculation. |
1995 |
Transplant. Proc. |
pmid:7533410
|
Charters AR et al. |
Developmental expression of FK506 binding proteins and calcineurin in rat brain. |
1995 |
Biochem. Soc. Trans. |
pmid:8566310
|
Tanabe M et al. |
Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation. |
1995 |
Transplant. Proc. |
pmid:7533411
|
Abu-Elmagd K et al. |
The current status of hepatic transplantation at the University of Pittsburgh. |
1995 |
Clin Transpl |
pmid:8794262
|
Masri MA |
Comparative study of toxicity and efficacy of cyclosporine, cyclosporine G (OG37), FK 506, and rapamycin in BALB/c mice with fitted skin grafts. |
1995 |
Transplant. Proc. |
pmid:7533412
|
Shapiro R et al. |
The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience. |
1995 |
Clin Transpl |
pmid:8794266
|
Jiang H et al. |
Immunosuppressive effects of FK 506 on rat renal allograft survival, in comparison with cyclosporine. |
1995 |
Transplant. Proc. |
pmid:7533413
|
Bismuth H |
Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group. |
1995 |
Transplant. Proc. |
pmid:7533415
|
Sen J et al. |
Expression and induction of nuclear factor-kappa B-related proteins in thymocytes. |
1995 |
J. Immunol. |
pmid:7534792
|
Komori T |
[The change of lymphocyte subset and effect of FK506 in experimental small bowel transplantation of rats]. |
1995 |
Nihon Geka Gakkai Zasshi |
pmid:7534867
|
Woo J et al. |
Combined effects of FK506 (tacrolimus) and cyclophosphamide on atypical B220+ T cells, cytokine gene expression and disease activity in MRL/MpJ-lpr/lpr mice. |
1995 |
Clin. Exp. Immunol. |
pmid:7535208
|
Jusko WJ et al. |
Pharmacokinetics of tacrolimus in liver transplant patients. |
1995 |
Clin. Pharmacol. Ther. |
pmid:7535213
|
Hadley S et al. |
Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. |
1995 |
Transplantation |
pmid:7535482
|
Bakhtiar R and Stearns RA |
Studies on non-covalent associations of immunosuppressive drugs with serum albumin using pneumatically assisted electrospray ionization mass spectrometry. |
1995 |
Rapid Commun. Mass Spectrom. |
pmid:7535601
|
Ockenfels HM et al. |
Cyclosporin A, FK506 and dithranol after tyrosine-specific protein phosphorylation in HaCaT keratinocytes. |
1995 |
Arch. Dermatol. Res. |
pmid:7541191
|
Victor RG et al. |
Presynaptic modulation of cortical synaptic activity by calcineurin. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7541535
|
Kaufman DB et al. |
The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome. |
1995 |
Transplantation |
pmid:7541579
|
Hemenway C |
FK506 in bone marrow transplantation. |
1995 |
Blood |
pmid:7579473
|
McDiarmid SV et al. |
The treatment of intractable rejection with tacrolimus (FK506) in pediatric liver transplant recipients. |
1995 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:7541834
|
Yamamoto M et al. |
Cyclosporin A and FK506 reverse anthracycline resistance by altering the cell cycle. |
1995 |
Anticancer Drugs |
pmid:7579561
|
O'Gorman MA et al. |
Proximal renal tubular acidosis secondary to FK506 in pediatric liver transplant patients. |
1995 |
Clin Transplant |
pmid:7579739
|
Saito T et al. |
In situ dephosphorylation of tau by protein phosphatase 2A and 2B in fetal rat primary cultured neurons. |
1995 |
FEBS Lett. |
pmid:7498550
|
Kanamaru A et al. |
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group. |
1995 |
Bone Marrow Transplant. |
pmid:7581086
|
Iwabuchi T et al. |
Effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation in mouse: immunosuppression is not required for new hair growth. |
1995 |
J. Dermatol. Sci. |
pmid:7537082
|
Antoni FA et al. |
Calcineurin feedback inhibition of agonist-evoked cAMP formation. |
1995 |
J. Biol. Chem. |
pmid:7499291
|
Koehler MT et al. |
FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation. |
1995 |
Bone Marrow Transplant. |
pmid:7581088
|
Arnold JC and Theilmann L |
[Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation]. |
1995 |
Z Gastroenterol |
pmid:7502559
|
Reisman L et al. |
Modulation of interleukin-1 secretion by immunosuppressive drugs, alone and in combination. |
1995 |
Transpl. Immunol. |
pmid:7551978
|
Osman A et al. |
Schistosoma mansoni: characterization of p50, an immunophilin. |
1995 |
Exp. Parasitol. |
pmid:7537219
|
Woo J et al. |
Effects of FK 506 on chimerism and the induction of donor-specific unresponsiveness following fully allogeneic bone marrow transplantation in mice. |
1995 |
Transpl. Immunol. |
pmid:7551985
|
Tanida I et al. |
Cooperation of calcineurin and vacuolar H(+)-ATPase in intracellular Ca2+ homeostasis of yeast cells. |
1995 |
J. Biol. Chem. |
pmid:7537264
|
Kelly PA et al. |
Tacrolimus: a new immunosuppressive agent. |
1995 |
Am J Health Syst Pharm |
pmid:7552894
|
Koch K et al. |
The C-32 triacetyl-L-rhamnose derivative of ascomycin: a potent, orally active macrolactone immunosuppressant. |
1995 |
J. Med. Chem. |
pmid:7537331
|
Torii N et al. |
An inhibitor for calcineurin, FK506, blocks induction of long-term depression in rat visual cortex. |
1995 |
Neurosci. Lett. |
pmid:7537357
|
Miyazawa H et al. |
Hamster to rat kidney xenotransplantation. Effects of FK 506, cyclophosphamide, organ perfusion, and complement inhibition. |
1995 |
Transplantation |
pmid:7537396
|
Pockley AG et al. |
Effect of cyclosporin A, FK506 and rapamycin on proliferation and soluble IL-2 receptor release from mitogenically stimulated rat spleen cells. |
1995 |
Biochem. Soc. Trans. |
pmid:8654800
|
Furlan V et al. |
Interactions between FK506 and rifampicin or erythromycin in pediatric liver recipients. |
1995 |
Transplantation |
pmid:7537398
|
Migita K et al. |
FK506 augments activation-induced programmed cell death of T lymphocytes in vivo. |
1995 |
J. Clin. Invest. |
pmid:7543492
|
Lhoëst G et al. |
The in vitro immunosuppressive activity of the C15-demethylated metabolite of FK-506 is governed by ring- and open-chain tautomerism effects. |
1995 |
J. Pharmacol. Exp. Ther. |
pmid:7543569
|
Textor SC et al. |
Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation. |
1995 |
Kidney Int. |
pmid:7543625
|
Dollinger MM et al. |
Tacrolimus and cardiotoxicity in adult liver transplant recipients. |
1995 |
Lancet |
pmid:7543645
|
Fealy MJ et al. |
Association of down-regulation of cytokine activity with rat hind limb allograft survival. |
1995 |
Transplantation |
pmid:7539555
|
Romero DF et al. |
Rapamycin: a bone sparing immunosuppressant? |
1995 |
J. Bone Miner. Res. |
pmid:7543725
|
Rebollo A et al. |
Differential effect of rapamycin and cyclosporin A in proliferation in a murine T cell line expressing either intermediate or high affinity receptor for IL-2. |
1995 |
Cytokine |
pmid:7543780
|
Lam E et al. |
Isolation of a cDNA encoding a novel human FK506-binding protein homolog containing leucine zipper and tetratricopeptide repeat motifs. |
1995 |
Gene |
pmid:7543869
|
Hisatomi K et al. |
Changes in the mononuclear cell subpopulations of rat cardiac transplant recipients administered FK506 for the treatment of ongoing rejection. |
1995 |
Surg. Today |
pmid:7539647
|
Minamoto A et al. |
Suppression of corneal graft rejection by subconjunctival injection of FK-506 in a rat model of penetrating keratoplasty. |
1995 |
Jpn. J. Ophthalmol. |
pmid:7543958
|
Ueda M et al. |
A proposal of FK506 optimal dosing in living related liver transplantations. |
1995 |
Transplantation |
pmid:7544035
|
Tamura K et al. |
Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. |
1995 |
Transplantation |
pmid:7539960
|
Muthukkumar S et al. |
Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells. |
1995 |
Transplantation |
pmid:7544036
|
Fisher A et al. |
FK506 hepatotoxicity in liver allograft recipients. |
1995 |
Transplantation |
pmid:7539961
|
Nash RA et al. |
Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study. |
1995 |
Blood |
pmid:7540071
|
Bennett WM |
The nephrotoxicity of immunosuppressive drugs. |
1995 |
Clin. Nephrol. |
pmid:7540121
|
Moro A et al. |
Secretion by Trypanosoma cruzi of a peptidyl-prolyl cis-trans isomerase involved in cell infection. |
1995 |
EMBO J. |
pmid:7540135
|
Teague S |
Lessons from molecular matchmakers. |
1995 |
Nat. Struct. Biol. |
pmid:7545076
|
Ito T et al. |
Immunosuppressive agents induce the reduction of local pancreatic blood flow. |
1995 |
Pancreas |
pmid:7545292
|
Han CW et al. |
Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression. |
1995 |
Bone Marrow Transplant. |
pmid:7545487
|
Jindal RM and Popescu I |
Renal dysfunction associated with liver transplantation. |
1995 |
Postgrad Med J |
pmid:7479462
|
Hattori Y and Nakanishi N |
Effects of cyclosporin A and FK506 on nitric oxide and tetrahydrobiopterin synthesis in bacterial lipopolysaccharide-treated J774 macrophages. |
1995 |
Cell. Immunol. |
pmid:7545550
|
Yeh WC et al. |
Identification and characterization of an immunophilin expressed during the clonal expansion phase of adipocyte differentiation. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7479941
|
Han JW et al. |
Rapamycin, wortmannin, and the methylxanthine SQ20006 inactivate p70s6k by inducing dephosphorylation of the same subset of sites. |
1995 |
J. Biol. Chem. |
pmid:7545671
|
Yeh WC et al. |
Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7479942
|
Ruff VA and Leach KL |
Direct demonstration of NFATp dephosphorylation and nuclear localization in activated HT-2 cells using a specific NFATp polyclonal antibody. |
1995 |
J. Biol. Chem. |
pmid:7545680
|
Shaw KT et al. |
Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. |
1995 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7479966
|
Matsuo S and Okamoto K |
Enhancement of FK-506 activities by ganglioside (GM3) in vivo. |
1995 |
Life Sci. |
pmid:7545772
|
Annesley TM et al. |
Stability of tacrolimus (FK 506) and cyclosporin G in whole blood. |
1995 |
Ther Drug Monit |
pmid:7482690
|
Lampen A et al. |
Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability. |
1995 |
Drug Metab. Dispos. |
pmid:8689938
|
Lake JR et al. |
The impact of immunosuppressive regimens on the cost of liver transplantation--results from the U.S. FK506 multicenter trial. |
1995 |
Transplantation |
pmid:7482713
|
Mathew A et al. |
Reversal of steroid-resistant rejection in renal allograft recipients using FK506. |
1995 |
Transplantation |
pmid:7482730
|
Zhu D et al. |
Myristoylation of calcineurin B is not required for function or interaction with immunophilin-immunosuppressant complexes in the yeast Saccharomyces cerevisiae. |
1995 |
J. Biol. Chem. |
pmid:7559604
|
Henley SE et al. |
Lipids following pancreas transplantation in recipients receiving FK 506. |
1995 |
Transplant. Proc. |
pmid:8539809
|
Stratta RJ et al. |
Preliminary experience with FK 506 in pancreas transplant recipients. |
1995 |
Transplant. Proc. |
pmid:8539823
|